These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8643200)

  • 1. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients.
    Perez-Garcia R; Anaya F; Chisvert J; Valderrabano F
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164-6. PubMed ID: 8643200
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ultrafiltered dialysate is associated with improvements in haemodialysis-associated morbidity in patients treated with reused dialysers.
    Ouseph R; Jones S; Dhananjaya N; Ward RA
    Nephrol Dial Transplant; 2007 Aug; 22(8):2269-75. PubMed ID: 17400564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of pyrexia in patients undergoing haemodialysis.
    Egwari LO; Mendie UE
    West Afr J Med; 1996; 15(2):101-6. PubMed ID: 8855673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short bacterial DNA fragments: detection in dialysate and induction of cytokines.
    Schindler R; Beck W; Deppisch R; Aussieker M; Wilde A; Göhl H; Frei U
    J Am Soc Nephrol; 2004 Dec; 15(12):3207-14. PubMed ID: 15579524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis.
    Lonnemann G; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():17-22. PubMed ID: 11402092
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbiological quality requirements for dialysate: is it time for a change?
    Ward RA; Sadler JH
    Nephrol News Issues; 2002 Nov; 16(12):26-29, 33-4, 36 passim. PubMed ID: 12452108
    [No Abstract]   [Full Text] [Related]  

  • 8. High level of recovery of fungi from water and dialysate in haemodialysis units.
    Arvanitidou M; Spaia S; Velegraki A; Pazarloglou M; Kanetidis D; Pangidis P; Askepidis N; Katsinas C; Vayonas G; Katsouyannopoulos V
    J Hosp Infect; 2000 Jul; 45(3):225-30. PubMed ID: 10896802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating total urea removal and protein catabolic rate by monitoring UV absorbance in spent dialysate.
    Uhlin F; Fridolin I; Lindberg LG; Magnusson M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2458-64. PubMed ID: 16077147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid evolutionary papules in a uremic patient.
    Chen SC; Chang HC; Chu SJ; Wu CP; Tsai SH
    J Trauma; 2007 Aug; 63(2):449. PubMed ID: 17693851
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of the bacteriologicalcontamination of a water treatment line used for haemodialysis and its disinfection.
    Morin P
    J Hosp Infect; 2000 Jul; 45(3):218-24. PubMed ID: 10896801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
    Heinz J; Domröse U; Westphal S; Luley C; Neumann KH; Dierkes J
    Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of fungi in water used at a haemodialysis centre.
    Pires-Gonçalves RH; Sartori FG; Montanari LB; Zaia JE; Melhem MS; Mendes-Giannini MJ; Martins CH
    Lett Appl Microbiol; 2008 May; 46(5):542-7. PubMed ID: 18363650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
    Masakane I
    Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anaphylactic shock in hemodialysis: apropos of 2 cases].
    Bouvier P; Barnouin F; Briat C; Soutif C; Pollini J
    Nephrologie; 1989; 10(1):40-1. PubMed ID: 2716943
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of contaminated dialysate in hemodialysis-associated cytokine production.
    Lonnemann G
    Contrib Nephrol; 1990; 86():121-7. PubMed ID: 2078948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood purification and endotoxin].
    Suzue N; Minakuti J
    Nihon Rinsho; 2004 May; 62 Suppl 5():223-6. PubMed ID: 15197919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proatherogenic changes induced by hemodialysis; probably a result of bio-incompatibility].
    Nubé MJ; Vervloet MG
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2540-4. PubMed ID: 11191788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
    Attman PO; Ottosson P; Samuelsson O; Eriksson UG; Eriksson-Lepkowska M; Fager G
    Nephrol Dial Transplant; 2005 Sep; 20(9):1889-97. PubMed ID: 15928099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.